Michael Nebozhyn
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)University of South Florida(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research, RNA modifications and cancer
Most-Cited Works
- → IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade(2017)3,762 cited
- → Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy(2018)2,281 cited
- → Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes(2015)2,207 cited
- → Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling(2011)396 cited
- → Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study(2009)356 cited
- → EMT is the dominant program in human colon cancer(2011)278 cited
- → A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC